以双特异性抗体 XmAb 18968 靶向 CD38 治疗复发/难治性急性髓系白血病和 T 细胞急性淋巴细胞白血病患者
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
82.5分
★★★★☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 6
具有 CD38(-)CD73(-)Tim-3(-)HLA-DR(+) 表型的 CAR-T 细胞预测 tisagenlecleucel 治疗 B 细胞前体 ALL 的疗效
CAR-T cells with the CD38(-)CD73(-)Tim-3(-)HLA-DR(+) phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL.
77.1分
★★★★☆
站内排序·非疗效
SOHO 最新进展更新与后续问题：T-ALL 新型疗法：从 CAR-T 到新靶点
SOHO State of the Art Updates and Next Questions: Novel Therapies in T-ALL: From CAR-T to Novel Targets.
52.2分
★★★☆☆
站内排序·非疗效
CD38 作为 CAR-T 细胞的泛血液肿瘤靶点
CD38 as a pan-hematologic target for chimeric antigen receptor T cells.
47.2分
★★★☆☆
站内排序·非疗效
免疫治疗在成人急性白血病治疗中处于何种地位？
Where do immunotherapies stand in management of acute leukemia in adults?
43.3分
★★☆☆☆
站内排序·非疗效
OMIP-106：用于分析急性髓系白血病患者骨髓中检查点抑制网络的 30 色方案
OMIP-106: A 30-color panel for analysis of check-point inhibitory networks in the bone marrow of acute myeloid leukemia patients.
33.1分
★☆☆☆☆
站内排序·非疗效
共 6 条